Esafosfina belongs to the group of electrolyte solution drugs that regulate water-electrolyte balance and acid-base equilibrium, containing key ingredients such as sodium salts of fructose-1,6-diphosphate. Esafosfina 5g/50ml is indicated for patients with myocardial infarction, shock treatment, and severe ischemia in the lower limbs.